FDA Inspection 1305396 — Wyeth Pharmaceutical Division Of Wyeth Holdings LLC
The FDA completed an inspection of Wyeth Pharmaceutical Division Of Wyeth Holdings LLC on Apr 23, 2026 in Sanford, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 23, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Sanford, NC (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3561 | 21 CFR 211.56(b) | Written sanitation procedures lacking |